Alkermes is a biopharmaceutical company that develops and sells pharmaceutical products for various medical conditions in the US and other countries. Some of their marketed products include ARISTADA, VIVITROL, RISPERDAL CONSTA, INVEGA SUSTENNA and VUMERITY for the treatment of conditions such as schizophrenia, alcohol dependence, bipolar disorder, and multiple sclerosis. The company is also working on developing LYBALVI and nemvaleukin alfa as oral antipsychotic drug candidates and tumor-killing immune cells.